Exact Mass: 461.1951
Exact Mass Matches: 461.1951
Found 192 metabolites which its exact mass value is equals to given mass value 461.1951
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Orphenadrine citrate
M - Musculo-skeletal system > M03 - Muscle relaxants > M03B - Muscle relaxants, centrally acting agents > M03BC - Ethers, chemically close to antihistamines D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant Orphenadrine citrate is an orally active and non-competitive NMDA receptor antagonist (crosses the blood-brain barrier) with a Ki of 6.0 μM. Orphenadrine citrate relieves stiffness, pain and discomfort due to muscle strains, sprains or other injuries. Orphenadrine citrate is also used to relieve tremors associated with parkinson's disease. Orphenadrine citrate has good neuroprotective properties, can be used in studies of neurodegenerative diseases[1][2].
Embusartan
Ala Ala Asp Trp
Ala Ala Trp Asp
Ala Asp Ala Trp
Ala Asp Trp Ala
Ala Glu Gly Trp
Ala Glu Trp Gly
Ala Gly Glu Trp
Ala Gly Trp Glu
Ala Trp Ala Asp
Ala Trp Asp Ala
Ala Trp Glu Gly
Ala Trp Gly Glu
Cys Asp Lys Pro
Cys Asp Pro Lys
Cys Lys Asp Pro
Cys Lys Pro Asp
Cys Pro Asp Lys
Cys Pro Lys Asp
Asp Ala Ala Trp
Asp Ala Trp Ala
Asp Cys Lys Pro
Asp Cys Pro Lys
Asp Asp Gly Arg
Asp Asp Arg Gly
Asp Gly Asp Arg
Asp Gly Arg Asp
Asp Lys Cys Pro
Asp Lys Pro Cys
Asp Pro Cys Lys
Asp Pro Lys Cys
Asp Arg Asp Gly
Asp Arg Gly Asp
Asp Trp Ala Ala
Glu Ala Gly Trp
Glu Ala Trp Gly
Glu Gly Ala Trp
Glu Gly Trp Ala
Glu Trp Ala Gly
Glu Trp Gly Ala
Gly Ala Glu Trp
Gly Ala Trp Glu
Gly Asp Asp Arg
Gly Asp Arg Asp
Gly Glu Ala Trp
Gly Glu Trp Ala
Gly Arg Asp Asp
Gly Trp Ala Glu
Gly Trp Glu Ala
Lys Cys Asp Pro
Lys Cys Pro Asp
Lys Asp Cys Pro
Lys Asp Pro Cys
Lys Pro Cys Asp
Lys Pro Asp Cys
Met Asn Pro Thr
Met Asn Thr Pro
Met Pro Asn Thr
Met Pro Gln Ser
Met Pro Ser Gln
Met Pro Thr Asn
Met Gln Pro Ser
Met Gln Ser Pro
Met Ser Pro Gln
Met Ser Gln Pro
Met Thr Asn Pro
Met Thr Pro Asn
Asn Met Pro Thr
Asn Met Thr Pro
Asn Asn Asn Thr
Asn Asn Gln Ser
Asn Asn Ser Gln
Asn Asn Thr Asn
Asn Pro Met Thr
Asn Pro Thr Met
Asn Gln Asn Ser
Asn Gln Ser Asn
Asn Ser Asn Gln
Asn Ser Gln Asn
Asn Thr Met Pro
Asn Thr Asn Asn
Asn Thr Pro Met
Pro Cys Asp Lys
Pro Cys Lys Asp
Pro Asp Cys Lys
Pro Asp Lys Cys
Pro Lys Cys Asp
Pro Lys Asp Cys
Pro Met Asn Thr
Pro Met Gln Ser
Pro Met Ser Gln
Pro Met Thr Asn
Pro Asn Met Thr
Pro Asn Thr Met
Pro Gln Met Ser
Pro Gln Ser Met
Pro Ser Met Gln
Pro Ser Gln Met
Pro Thr Met Asn
Pro Thr Asn Met
Gln Met Pro Ser
Gln Met Ser Pro
Gln Asn Asn Ser
Gln Asn Ser Asn
Gln Pro Met Ser
Gln Pro Ser Met
Gln Ser Met Pro
Gln Ser Asn Asn
Gln Ser Pro Met
Arg Asp Asp Gly
Arg Asp Gly Asp
Arg Gly Asp Asp
Ser Met Pro Gln
Ser Met Gln Pro
Ser Asn Asn Gln
Ser Asn Gln Asn
Ser Pro Met Gln
Ser Pro Gln Met
Ser Gln Met Pro
Ser Gln Asn Asn
Ser Gln Pro Met
Thr Met Asn Pro
Thr Met Pro Asn
Thr Asn Met Pro
Thr Asn Asn Asn
Thr Asn Pro Met
Thr Pro Met Asn
Thr Pro Asn Met
Trp Ala Ala Asp
Trp Ala Asp Ala
Trp Ala Glu Gly
Trp Ala Gly Glu
Trp Asp Ala Ala
Trp Glu Ala Gly
Trp Glu Gly Ala
Trp Gly Ala Glu
Trp Gly Glu Ala
Embusartan
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist